牟田 真理子
Faculty

学部・大学院

牟田 真理子

所属 健康メディカル学部 健康栄養学科 准教授
最終学歴 共立薬科大学大学院薬学研究科博士後期課程
現在所属している学会 日本癌学会、がん分子標的治療学会、日本栄養改善学会、日本栄養・食糧学会、日本咀嚼学会、日本乳癌学会、がんサポーティブケア学会
学士・修士・博士 家政学士,修士(薬学),博士(薬学)
所有資格 管理栄養士、栄養士
研究の分野 生活科学、腫瘍学
主な研究項目 がんと栄養
主な研究業績 食品群別摂取量と咬合圧・咀嚼能力の関連についての検討~若齢成人を対象として~/第61回日本栄養改善学会学術総会/共著/2014.08
Potential beneficial effects of ginger on chemotherapy in breast cancer/OOTR (Organisation for Oncology and Translational Research) the 8th Annual Conference/共著/2012.04
がん化学療法に対するショウガによる効果の検討/第69回日本癌学会学術総会 (大阪)2010.9.23(ポスター)/共著/2010.09
Effects of ginger on cancer chemotherapy/The 6th Annual Conference of OOTR (Kyoto Japan) 26-27,Feburary 2010.(ポスター)/共著/2010.02
Effects of paclitaxel and docetaxel on endothelial progenitor cells in a rat tumor model/The 8th Cerebral Vascular Biology International Conference (Sendai Japan) 28 June~2 July 2009.(ポスター)/共著/2009.07
Docetaxel,Paclitaxelの血管内皮前駆細胞への作用と血管新生阻害効果の検討/第12回がん分子標的治療研究会総会、東京、2008.6.26(口演)/共著/2008.06
Inhibition of Vasculogenesin on Endothelial Progenitor Cell Line TR-BME by Docetaxel and Paclitaxel;/The 4th Annual Conference of OOTR (Kyoto,Japan) 9.November 2007 (poster)/共著/2007.11
Inhibition of Vasculogenesis on Endothelial Progenitor Cell Line TR-BME by Docetaxel and Paclitaxel./第66回日本癌学会総会 横浜、2007.10.3(ポスター)/共著/2007.10
血管内皮前駆細胞株TR-BMEに対するドセタキセル及びパクリタキセルの感受性評価/第6回日本再生医療学会総会, 横浜、 2007.3.13.(ポスター)/共著/2007.03
正常血管と腫瘍血管/生体の化学:57(6):580-584 2006 Nov.-Dec./共著/2006.11
脈管形成が固形腫瘍に及ぼす血管新生促進効果とMCP-1の関与/第64回日本癌学会総会 札幌、2005.9.14(ポスター)/共著/2005.09
腫瘍血管と正常血管の差異と抗腫瘍血管新生療法/わかる実験医学シリーズ 基礎から臨床応用までの血管研究がわかる(羊土社)2004.10.12発行/共著/2004.10
血管内皮前駆細胞の腫瘍特異的集積におけるVEGF,MCP-1の関与/第63回日本癌学会総会 福岡、2004.9.30(ポスター)/共著/2004.09
Study of cancer gene therapy using IL-12-secreting endothelial progenitor cells in a rat solid tumor model.;2003/AAPS Annual Meeting and Exposition(Salt Lake City,USA)29.October 2003. (poster)/共著/2003.10
IL-12 遺伝子導入血管内皮前駆細胞の腫瘍特異的集積性と癌治療効果/第62回日本癌学会総会 名古屋、2003.9.26(口演)/共著/2003.09
脈管形成と免疫による腫瘍増殖の調節/第61回日本癌学会総会 東京、2002.10.1(ワークショップ)/共著/2002.10
Tumor-targeting of cell therapy using gene-transfedted endothelial progenitor cells./The 1st Korea-Japan Joint Symposium on Drug Delivery and Therapy(Korea,Seoul) 19.April 2002. (poster)/共著/2002.04
Recruitment of bone marrow-derived endothelial cells to the in vivo malignant tumor by comparison with other organs./World Congress of Pharmacy and Pharmaceutical Sciences 2001.,61st International Congress of FIP.(Singapore) 1-6 September 2001.(poster)/共著/2001.09
ラット骨髄由来血管内皮前駆細胞株の生体内動態と腫瘍血管新生への関与/第60回日本癌学会総会 横浜、2001.9.26(ポスター)/共著/2001.01
Established of conditionally immortalized endothelial cell lines(TR-BME)derived from rat bone marrow./Millennial world congress of pharmaceutical scienses.(san Francisco USA)16-20 April 2000. (poster)/共著/2000.04
条件的不死化骨髄由来内皮細胞株(TR-BME)の樹立/日本薬学会第120年会 岐阜、2000.3.30(ポスター)/共著/2000.03
咀嚼・咬合状況と食品別摂取量との関連についての検討ー若年者を対象としてー/日本咀嚼学会雑誌 J.Masticat & Health Soc.2019;29(1):8-16/共著/2019.05
Basic fibroblast growth factor is essential to maintain endotherial progenitor cell phenotype in TR-BME2 cells.(査読付)/Biological and Pharmaceutical Bulletin. 2014;37(4):688-693/共著/2014.04
Genome-wide copy number analysis in primary breast cancer. (査読付)/Expert Opin Ther Targets. 2012 Mar;16 Suppl 1:S31-5./共著/2012.03
Roles of TauT and system A in cytoprotection of rat syncytiotrophoblast cell line exposed to hypertonic stress. (査読付)/Placenta.2010 Nov;31(11):1003-9./共著/2010.11
Effect of low-dose Paclitaxel and docetaxel on endothelial progenitor cells.(査読付)/Oncology. 2009;77(3-4):182-91./共著/2009.09
Altered Expression of Basement Membrane-ralated Molecules in Rat Brain Pericyte,Endothelial,and Astrocyte Cell Lines after Transforming Growth Factor-betal Treatment.(査読付)/Drug Metab Pharmacokinet.2007;22(4):255-66./共著/2007.08
Tumorsize significantly correlates with postoperative liver metastases and COX-2 eexpression in patients with resectable pancreatic cancer.(査読付)/Pancreatology 2007;7(2-3);167-73./共著/2007.07
A nonfucosylated anti-HER2 antibody augments antibody-dependent cellular cytotoxicity in breast cancer patients.(査読付)/Clin Cancer Res.2007;13(6):1875-82./共著/2007.03
Mechanical analysis of tumor growth regression by the cyclooxygenase-2 inhibitor,DFU,in a Walker256 rat tumor model:importance of monocyte chemoattractant protein-1 modulation.(査読付)/Clin Cancer Res.2006;12(1):264-72./共著/2006.01
Enhancement of the caspase-independent apoptotic sensitivity of pancreatic canser cells by DHMEQ,an NF-kappaB inhibitor.(査読付)/Int J Oncol.2005;27(5):1247-55./共著/2005.11
Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin,a novel inhibitor of breast carcinomas:antitumor and antiangiogenic potential in vivo.(査読付)/Clin Cance Res.2005;11(3):1287-93./共著/2005.02
DFU,a selective COX-2 inhibitor,suppresses MCF-7 xenograft tumor growth in mice.(査読付)/Oncol Rep.2004;12(2):281-5./共著/2004.08
Modulation of Thimidine phosphorylase by necoadjuvant chemotherapy in priimary breast cancer.(査読付)/Br. J.Cancer.2004;90(12);2338-43./共著/2004.06
Study of cancer gene theapy using IL-12-secreting endothelial progenitor cells in a rat solid tumor model.(査読付)/Oncol Rep.2003 10(6):1765-9./共著/2003.11
Survival benefit of KRN7000 immune therapy in combination with TNP470 in hamster liver metastasis model of pancreatic cancer.(査読付)/Oncol Rep.2003;10(5):1201-6/共著/2003.09
Impact of vasculogenesis on solid tumor growth in a rat model.(査読付)/Oncol Rep.2003;10(5):1213-8./共著/2003.09
Immunohistochemical analysis of estrone sulfatase and aromatase in human breast cancer tissues.(査読付)/Oncol Rep.2003;10(4)791-6./共著/2003.07
Significance of vascular endothelial growth factor(VEGF)/soluble VEGF receptor-1 relationship in breast cancer.(査読付)/Int Jcancer.2002;98(1);14-8./共著/2002.05
Expression of macrophage migration inhibitory factor in human breast cancer:association with nodal spread.(査読付)/Jpn J Cancer Res.2002;93(4):389-96./共著/2002.04
Establishment of Bone Marrow-Derived Endothelial Cell Lines From ts-SV40 T-antigen Gene Transgenic Rats.(査読付)/Pharmaceut.Res.2001;18(1):9-15/共著/2001.01
Significance of Macrophage Chemoattractant Protein 1 in Macrophage recruitment,Angiogenesis,and Survival in Human Breast Cancer.(査読付)/Clin.Cancer Res.2000; 6(8):3282-9./共著/2000.08
Significance of Membrane Type 1 Matrix Metalloproteinase Expression in Breast Cancer.(査読付)/Jpn.J.Cancer Res. 1999; 90(5),516-22./共著/1999.05
Role of MDM2 overexpression in doxorubicin resistance of breast carcinoma.(査読付)/Jpn J Cancer Res.1998;89(2):221-7/共著/1998.02
主な担当授業科目名 栄養教育論Ⅰ、Ⅱ、Ⅲ、栄養教育論実習